Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Cytokinetics Stock Forecast NASDAQ:CYTK
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-16 | 100.75% | Mizuho | $54.00 $80.00 | Maintains | Buy |
| 2022-05-05 | 50.56% | Needham | $52.00 $60.00 | Maintains | Buy |
| 2022-04-29 | 88.21% | HC Wainwright & Co. | $69.00 $75.00 | Maintains | Buy |
| 2021-12-22 | 38.02% | Oppenheimer | $55.00 | Initiates Coverage On | Outperform |
| 2021-12-21 | 73.15% | HC Wainwright & Co. | $62.00 $69.00 | Maintains | Buy |
| 2021-12-10 | 45.55% | JP Morgan | $58.00 | Initiates Coverage On | Overweight |
| 2021-12-01 | 35.51% | Mizuho | $45.00 $54.00 | Maintains | Buy |
| 2021-11-04 | 55.58% | HC Wainwright & Co. | $58.00 $62.00 | Maintains | Buy |
| 2021-10-08 | 12.92% | Morgan Stanley | $38.00 $45.00 | Maintains | Overweight |
| 2021-10-07 | 88.21% | Jefferies | $75.00 | Initiates Coverage On | Buy |
| 2021-08-06 | 45.55% | HC Wainwright & Co. | $53.00 $58.00 | Maintains | Buy |
| 2021-07-20 | 0.38% | Barclays | $28.00 $40.00 | Maintains | Overweight |
| 2021-07-19 | 20.45% | Needham | $33.00 $48.00 | Maintains | Buy |
| 2021-07-19 | 33% | HC Wainwright & Co. | $41.00 $53.00 | Maintains | Buy |
| 2021-04-19 | -12.17% | Morgan Stanley | $24.00 $35.00 | Maintains | Overweight |
| 2021-03-12 | 25.47% | Wolfe Research | $50.00 | Initiates Coverage On | Outperform |
| 2021-01-20 | 2.89% | HC Wainwright & Co. | $22.00 $41.00 | Maintains | Buy |
| 2020-12-16 | -39.77% | Morgan Stanley | $22.00 $24.00 | Maintains | Overweight |
| 2020-11-16 | -44.79% | Morgan Stanley | $24.00 $22.00 | Maintains | Overweight |
| 2020-10-29 | -59.85% | Goldman Sachs | $16.00 | Initiates Coverage On | Neutral |
| 2020-10-12 | -39.77% | Morgan Stanley | $35.00 $24.00 | Maintains | Overweight |
| 2020-10-08 | 7.9% | HC Wainwright & Co. | $59.00 $43.00 | Maintains | Buy |
| 2020-07-23 | 48.06% | HC Wainwright & Co. | $38.00 $59.00 | Maintains | Buy |
| 2020-07-23 | -9.66% | Piper Sandler | $33.00 $36.00 | Maintains | Overweight |
| 2020-07-16 | 12.92% | Needham | $34.00 $45.00 | Maintains | Buy |
| 2020-07-14 | -4.64% | HC Wainwright & Co. | $35.00 $38.00 | Maintains | Buy |
| 2020-07-10 | -2.13% | Raymond James | $39.00 | Initiates Coverage On | Strong Buy |
| 2020-07-07 | -12.17% | Morgan Stanley | $29.00 $35.00 | Maintains | Overweight |
| 2020-05-12 | -27.23% | Morgan Stanley | $25.00 $29.00 | Maintains | Overweight |
| 2020-05-05 | -22.21% | Mizuho | $31.00 | Initiates Coverage On | Buy |
| 2020-04-17 | -42.28% | Cantor Fitzgerald | $12.00 $23.00 | Reiterates | Overweight |
| 2020-04-09 | -37.26% | Morgan Stanley | $14.00 $25.00 | Upgrades | Equal-Weight Overweight |
| 2019-09-06 | -49.81% | Cantor Fitzgerald | $14.00 $20.00 | Reiterates | Overweight |
CYTK Stock Trend
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled.
Given the current short-term trend, the stock is expected to rise 9.62% during the next 3 months and, with a 90% probability hold a price between $38.55 and $49.56 at the end of this 3-month period.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-25 | $35.23 | $40.25 | $45.27 |
| 2022-05-26 | $35.30 | $40.32 | $45.34 |
| 2022-05-27 | $35.36 | $40.38 | $45.40 |
| 2022-05-31 | $35.43 | $40.45 | $45.47 |
| 2022-06-01 | $35.49 | $40.51 | $45.53 |
| 2022-06-02 | $35.56 | $40.58 | $45.60 |
| 2022-06-03 | $35.62 | $40.64 | $45.66 |
| 2022-06-06 | $35.69 | $40.71 | $45.73 |
| 2022-06-07 | $35.75 | $40.77 | $45.79 |
| 2022-06-08 | $35.82 | $40.84 | $45.86 |
| 2022-06-09 | $35.88 | $40.90 | $45.92 |
| 2022-06-10 | $35.95 | $40.97 | $45.99 |
| 2022-06-13 | $36.01 | $41.03 | $46.05 |
| 2022-06-14 | $36.08 | $41.10 | $46.12 |
| 2022-06-15 | $36.14 | $41.16 | $46.18 |
| 2022-06-16 | $36.21 | $41.23 | $46.25 |
| 2022-06-17 | $36.27 | $41.29 | $46.31 |
| 2022-06-21 | $36.34 | $41.36 | $46.38 |
| 2022-06-22 | $36.40 | $41.42 | $46.44 |
| 2022-06-23 | $36.47 | $41.49 | $46.51 |
| 2022-06-24 | $36.53 | $41.55 | $46.57 |
| 2022-06-27 | $36.60 | $41.62 | $46.64 |
| 2022-06-28 | $36.66 | $41.68 | $46.70 |
| 2022-06-29 | $36.73 | $41.75 | $46.77 |
| 2022-06-30 | $36.79 | $41.81 | $46.83 |
| 2022-07-01 | $36.86 | $41.88 | $46.90 |
| 2022-07-05 | $36.92 | $41.94 | $46.96 |
| 2022-07-06 | $36.99 | $42.01 | $47.03 |
| 2022-07-07 | $37.05 | $42.07 | $47.09 |
| 2022-07-08 | $37.12 | $42.14 | $47.16 |
Cytokinetics, Incorporated, a late stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. It is developing tirasemtiv, a fast skeletal muscle troponin activator that is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis; CK-2127107, which is in Phase II clinical trials for... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
